Literature DB >> 29260243

[Perioperative handling of antidiabetic drugs].

J Wagner1, V Luber2, J F Lock1, U A Dietz1, S Lichthardt1, N Matthes1, K Krajinovic1, C-T Germer1,3, S Knop2,3, A Wiegering4,5.   

Abstract

Diabetes mellitus is the most frequent metabolic disorder in the western world with a prevalence of 3% in adults under 65 years of age and 14.3% in adults over 65 years of age. Due to the increasing age of our population, the number of patients taking oral antidiabetic drugs has increased. Thus, operating physicians must make a risk-adapted decision whether the medication can be continued perioperatively or if certain drugs must be paused, and if so, with what risks. Operative interventions can lead to a number of metabolic shifts, which change the normal glucose metabolism. Hyperglycemia in the perioperative period is a risk factor for postoperative sepsis, dysfunction of the endothelium, cerebral ischemia and poor wound healing. Due to perioperative fasting oral antidiabetic medication can lead to severe hypoglycemia if taken during this period. This leads to an increased morbidity and mortality in the perioperative period and extends the duration of stay in the intensive care unit (ICU) as well as the overall hospital stay. Oral antidiabetic medication should be paused on the day of the operation and restarted in line with the gradual postoperative return to solid food. Especially metformin, the most commonly used medication in the treatment of type 2 diabetes, should be paused perioperatively due to the severe side effect of lactate acidosis.

Entities:  

Keywords:  Chronic medication; Hypoglycemia; Oral antidiabetic drugs; Preoperative pause; Risk stratification

Mesh:

Substances:

Year:  2018        PMID: 29260243     DOI: 10.1007/s00104-017-0527-8

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  14 in total

1.  NHS Diabetes guideline for the perioperative management of the adult patient with diabetes.

Authors:  K Dhatariya; N Levy; A Kilvert; B Watson; D Cousins; D Flanagan; L Hilton; C Jairam; K Leyden; A Lipp; D Lobo; M Sinclair-Hammersley; G Rayman
Journal:  Diabet Med       Date:  2012-04       Impact factor: 4.359

Review 2.  SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Authors:  Ele Ferrannini; Anna Solini
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

Review 3.  SGLT2-inhibitors: a novel class for the treatment of type 2 diabetes introduction of SGLT2-inhibitors in clinical practice.

Authors:  J Cuypers; C Mathieu; K Benhalima
Journal:  Acta Clin Belg       Date:  2013 Jul-Aug       Impact factor: 1.264

Review 4.  Perioperative management of diabetic patients undergoing hand surgery.

Authors:  Jason R Kang; Jeffrey Yao
Journal:  J Hand Surg Am       Date:  2015-05       Impact factor: 2.230

Review 5.  Glycaemic control in the perioperative period.

Authors:  J J Sebranek; A Kopp Lugli; D B Coursin
Journal:  Br J Anaesth       Date:  2013-12       Impact factor: 9.166

Review 6.  Metformin lactic acidosis and anaesthesia: myth or reality?

Authors:  R Vreven; M De Kock
Journal:  Acta Anaesthesiol Belg       Date:  2005

7.  Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward.

Authors:  Alexander Turchin; Michael E Matheny; Maria Shubina; James V Scanlon; Bonnie Greenwood; Merri L Pendergrass
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 19.112

Review 8.  Metformin-associated lactic acidosis: Current perspectives on causes and risk.

Authors:  Ralph DeFronzo; G Alexander Fleming; Kim Chen; Thomas A Bicsak
Journal:  Metabolism       Date:  2015-10-09       Impact factor: 8.694

Review 9.  Guidelines for Perioperative Management of the Diabetic Patient.

Authors:  Sivakumar Sudhakaran; Salim R Surani
Journal:  Surg Res Pract       Date:  2015-05-19

10.  Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland.

Authors:  P Barker; P E Creasey; K Dhatariya; N Levy; A Lipp; M H Nathanson; N Penfold; B Watson; T Woodcock
Journal:  Anaesthesia       Date:  2015-09-29       Impact factor: 6.955

View more
  1 in total

1.  Encapsulation of cinnamon oil in whey protein counteracts the disturbances in biochemical parameters, gene expression, and histological picture of the liver and pancreas of diabetic rats.

Authors:  Kamal A A Mohammed; Helmy M S Ahmed; Hafiza A Sharaf; Aziza A El-Nekeety; Sekena H Abdel-Aziem; Fathy M Mehaya; Mosaad A Abdel-Wahhab
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-13       Impact factor: 4.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.